AI driven screening Leverage iHealthScreen's AI-based eye and systemic disease screening capabilities to upsell to ophthalmology clinics, primary care networks, and community health organizations seeking scalable, predictive screening tools for Diabetic Retinopathy, glaucoma, and Age-Related Macular Degeneration.

Global expansion Target Bangladesh and other emerging markets where iHealthScreen has demonstrated regulatory progress and seed funding momentum, offering localized deployments, MHRA-aligned solutions, and partnerships with medical associations to accelerate adoption.

Public funding cues Capitalize on the company’s ongoing seed, pre-Series A funding activity and NIH-related financing to attract investors and potential channel partners by highlighting rapid deployment potential, government and NGO collaboration opportunities, and grant-driven pilots.

Accessible care Position the platform as a means to extend preventive eye and systemic health screening to under-resourced areas, aligning with payer and NGO programs that emphasize cost savings from early detection and reduced advanced treatment costs.

Tech stack leverage Propose integrations with existing clinical IT ecosystems using open tech stack elements (Python, Laravel, Linux) and marketing tags (LinkedIn Insight Tag, Site Kit, Facebook) to streamline onboarding, data interoperability, and targeted outreach to healthcare providers.